AMBI Inc. Changes Its Name to Nutrition 21, Inc.; New Nasdaq Trading Symbol is NXXI

Business Wire, March 8, 2001

Health/Medical Writers

PURCHASE, N.Y.--(BW HealthWire)--March 8, 2001

AMBI Inc. (Nasdaq: AMBI) today announced that its shareholders have approved a change in the Company's name to Nutrition 21, Inc.

The name change is effective immediately. The trading symbol of the common stock of the Company on the NASDAQ national market system will become NXXI effective Friday, March 9, 2001.

Gail Montgomery, Nutrition 21's President and Chief Executive Officer, commented, "Nutrition 21 is a name that underscores our expertise in nutrition and our science based approach to the market. The "N" in our new trading symbol highlights our expertise in nutrition, and the roman numeral XXI emphasizes our scientific leadership in the category as we move into the twenty first century. Nutrition 21, has been and will continue to be a leader in developing and marketing clinically substantiated essential trace minerals, ingredients, and consumer nutrition products. Our success in marketing Chromax(R) chromium picolinate, Selenomax(R) selenium, and Lite Bites(R), our weight control program, is based on our strong intellectual property franchise and impressive clinical expertise."

Nutrition 21 develops and market clinically substantiated products that make a significant contribution to the health and well being of consumers."

The words "believe," "expect," "anticipate" and other similar expressions generally identify forward-looking statements. Forward-looking statements are based on the company's current expectations and are subject to market, competitive and regulatory factors and the other risks and uncertainties indicated from time to time in the company's filings with the Securities and Exchange Commission. Actual results can differ materially. The company makes no commitment to disclose any revisions to forward-looking statements.